GlassScriptPhysician profile
Shellie R Kratzer
NPI 1700257565
$5,147.77
in general payments reported to CMS, 2019-2025
38 companies · $1,085 in 2025
The $1,085 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $621 · 2022: $1,121 · 2023: $1,311 · 2024: $1,009 · 2025: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,405.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $762.88 | 2021-2025 | |
| Novo Nordisk INC | $685.65 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $414.27 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $366.58 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $359.41 | 2021-2024 | Jardiance, Mounjaro, Emgality |
| Glaxosmithkline, LLC. | $322.60 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $296.17 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Abbott Laboratories | $216.86 | 2021-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $154.17 | 2021-2024 | Xifaxan |
| Exact Sciences Corporation | $146.27 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $140.16 | 2021-2024 | Veozah, Myrbetriq |
| Dexcom, INC. | $121.54 | 2023-2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $115.57 | 2022-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $92.79 | 2024 | |
| Sumitomo Pharma America, INC. | $76.07 | 2025 | Gemtesa |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shellie Kratzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.